The prognostic value of V-ATPase V1E1 expression in ESCC was lost in patients whose cancer cells expressed little or no p-PKM2 (Figure 7B, 7C), indicating that the impact of V-ATPase V1E1 on patient survival was dependent on p-PKM2 expression. This evidence concerns the gene PKM and esophageal squamous cell carcinoma.